16
Participants
Start Date
September 2, 2021
Primary Completion Date
March 26, 2024
Study Completion Date
March 26, 2024
INCB086550
INCB086550 will be administered orally twice a day.
Semmelweis Egyetem, Budapest
Complex Onclogy Center Plovdiv Eood, Plovdiv
"Multiprofile Hospital For Active Treatment Dr. Tota Venkova Jsc", Gabrovo
Bacs Kiskun Megyei Oktatokorhaz, Kecskemét
Complex Oncology Center - Burgas Eood, Burgas
Complex Oncology Center - Burgas Eood, Farkasgyepű
Shatod Dr. Marko - Varna Ltd, Varna
The Catholic University of Korea St. Vincent'S Hospital, Gyeonggi-do
Ajou University Hospital, Suwon
Chang Gung Memorial Hospital Linkou, Taoyuan
Rmi Sumy Regional Clinical Oncology Dispensary, Sumy
Volyn Regional Oncological Dispensary, Lutsk
Multifield Clinical Hospital No 4, Dnipro
Mi Kryviy Rih Center of Dnipropetrovsk Regional Council, Kryvyi Rih
Ci of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection, Kharkiv
Cne Ccch of Uzh Cc Oncological Center, Uzhhorod
Korea University Anam Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Medical Clinic Innovacia Llc, Vyshhorod
Lead Sponsor
Incyte Corporation
INDUSTRY